Alcohols

Random Miscellaneous Quiz

Can you name the Alcohols?

Quiz not verified by Sporcle

How to Play
Score 0/51 Timer 20:00
Play Game
HintAnswer
Drug P-kinetics: Zero order kinetics (saturatable). Ethanol converted to acetaldehyde by alcohol dehydrogenase (NAD+ required). Acetaldehyde converted to acetate by aldehyde dehydr
Clinical Use: Reduce seizure threshold and stop seizure activity during ethanol withdrawal
Drug SE: Allergies, tachycardia, BP changes, flatulence, impotence, GI distress & rash
Drug P-kinetics: Oral delayed release
Drug Tx: Key to dx is anion gap acidosis, osmolar gap, & oxalate crystals in urine. Tx: similar to methanol poisoning. 4-methylpyrazole (an inhibitor of alchohol dehydrogenase) if
Drug MOA: Inhibits aldehyde dehydrogenase producing accumulation of acetaldehyde after the consumption of alcohol
Drug MOA: Inhibits alcohol dehydrogenase
Drug Withdrawal Mgmt: Withdrawal symptoms (motor agitation, anxiety, insomnia, seizures, visual hallucinations, delirium tremens): Mild--thiamine, restore electrolytes. Moderate to
Drug use: Prevent the conversion of either ethylene glycol or methanol by alcohol dehydrogenase into toxic compounds (oxalic acid or formaldehyde, respectively).
Drug SE: Stages - 1) Acute Stage (minutes): excitation followed by CNS depression. 2) 4-12 hrs = severe metabolic acidosis (acid metabolites accumulate), anion gap & osmolar gap ac
Drug P-kinetics: Metabolized by alcohol dehydrogenase to formaldehyde. Formaldehyde is metabolized to CO2 by folate-dependent systems
Drug MOA: Required for synthesis of the coenzyme thiamine pyrophosphate
Lorazepam class
Drug Use: Deterrent to relapse in individuals w/ alcoholism. After one drink acetaldehyde accumulates producing unwanted side effects of HA, flushing, n/v, & hypotension
Fomepizole class
Naltrexone class
Drug P-kinetics: IV, oral short acting, no active metabolites,
Drug MOA: Increase frequency of firing of GABA-A chloride channels
Acute toxicity: dose dependent CNS depressant, CV depressant, smooth muscle relaxant.
Drug MOA & tox: Formaldehyde formed by conversion of methanol via alcohol dehydrogenase results in in toxicity
Chronic toxicity: liver dz, CA, accidents, suicide, chronic pancreatitis, gastritis, malabsorption of vitamins. Tolerance & dependence, Neurotoxicity (Wernicke-Korsakoff syndrome),
Drug P-kinetics: Oral
Drug P-kinetics: IV until asymptomatic
Drug P-kinetics: Oral short acting, no active metabolites,
Drug SE: Toxicities are why it is used. Inhibits metabolism of other drugs. Hepatotoxicity
Diazepam class
HintAnswer
Clinical Use: Used for methanol, ethylene glycol poisoning. Given IV (5-10% w/ 5% dextrose in H2O) to saturate alcohol dehydrogenase
Drug P-kinetics: IV
Disulfiram class
Drug MOA and tox: metabolized by alcohol dehydrogenase to oxalic acid.
Drug MOA: Alters membrane-bound neuronal ion conductance & GPCR receptors: Acute decrease NMDA channel conductance & increase GABA-A Cl- channel conductance. Chronic exposure: adap
Drug SE: Visual disturbances ('snow storm'), blurred vision, retinal damage. Formaldehyde on breath or urine, bradycardia, prolonged coma, seizures, severe metabolic acidosis w/ el
Oxazepam class
Drug Tx: Ethanol IV w/ dextrose in water or Fomepizole to inhibit conversion by alcohol dehydrogenase. Hemodialysis. Bicarbonate for acidosis. Folic acid to speed breakdown of form
Drug MOA: Competitive NMDA receptor antagonist?
Drugs use: Reduce cravings for alcohol & alcohol relapse (when given with counseling) in the short term. Reduces subjective 'high' assoc w/ alcohol.
Acamprosate class
Methanol class
Ethylene glycol class
Drug P-kinetics: IV, long acting--self tapering
Thiamine class (B1)
Drug to decrease chronic ethanol use
Drug Use: To prevent Wernicke-Korsakoff syndrome in chronic alcoholics
Drug SE: Hepatotoxicity, avoid w/ disulfiram. Precipitate withdrawal in patients using heroine or other opioids.
Drug Acute Mgmt: Prevent respiratory depression & aspiration, glucose to manage hypoglycemia & thiamine to protect against Wernicke-Korsakoff syndrome
Drug MOA: Opioid receptor antagonist. Mu opioid antagonist--decreases opioid binding in reward pathways
Drug P-kinetics: Alcohol dehydrogenase converts ethylene glycol into oxalic acid (renal toxic crystals)
Drug SE: none
Ethanol class
Drug P-kinetics: IM injections (monthly) or oral (Daily)
Drug SE: Seizures, HA, nausea, dizziness, rash, metallic taste, abnormal smell, rare allergic reactions.

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.
Challenge

You Might Also Like...

Extras

Created Aug 21, 2011ReportNominate
Tags:alcohol